GlobalGov › Germany › Pharmaceuticals › Solicitation

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Lopinavir und Ritonavir, ATC J05AR10

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 05, 2026
Response Due
Active
Status

Opportunity Overview

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Lopinavir und Ritonavir, ATC J05AR10 is a active solicitation for government procurement in Germany, issued by Health and tracked by GlobalGov. It falls under Pharmaceuticals. Responses are due by September 05, 2026. It was published on September 17, 2024. Full solicitation details, all dates, and related live opportunities are below.

This is one of 1,400 active Germany Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryPharmaceuticals
PublishedSeptember 17, 2024
Procurement stageActive solicitation
Response dueSeptember 05, 2026
StatusOpen — accepting responses
TranslationTranslated from German by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Pharmaceuticals tenders in Germany →Browse all categories →

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tralokinumab, ATC D11AH07 für die Zeit 01.08.2025 - 31.07.2027
Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Betamethason und Fusidinsäure (ATC: D07CC01)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Prednison (ATC: H02AB07)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Infliximab zur intravenösen Applikation
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Umeclidiniumbromid, ATC R03BB07
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Ebastin (ATC: R06AX22)
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Valproinsäure (N03AG01).
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-20 - Metformin/Dapagliflozin (Wirkstoffkombination)

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.